REGISTERED NUMBER: 09943476 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

M&M Medicare Limited

Page

Balance Sheet

1

Notes to the Financial Statements

3

Fixed assets

Tangible assets

4

1,524

2,033

Investment property

5

265,050

265,050

266,574

267,083

Current assets

Debtors

6

35,290

35,290

Cash at bank

24,329

29,165

59,619

64,455

Creditors

Amounts falling due within one year

7

(63,221

)

(61,667

)

Net current (liabilities)/assets

(3,602

)

2,788

Total assets less current liabilities

262,972

269,871

Creditors

Amounts falling due after more than one year

8

(28,704

)

(32,900

)

Net assets

234,268

236,971

Capital and reserves

Called up share capital

100

100

Retained earnings

234,168

236,871

Shareholders' funds

234,268

236,971

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 December 2025 and were signed on its behalf by:

Rana Ahmad - Director

Mrs Mariam Sohail - Director

Mrs Amatul Basit - Director

1.	Statutory information

M&M Medicare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

09943476

Registered office:

Marshall House, Suite 21/25

124 Middleton Road

Morden

SM4 6RW

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	Employees and directors

The average number of employees during the year was 3 (2024 - 2 ) .

4.	Tangible fixed assets

Fixtures

and

fittings

£

Cost

At 1 April 2024

and 31 March 2025

9,500

Depreciation

At 1 April 2024

7,467

Charge for year

509

At 31 March 2025

7,976

Net book value

At 31 March 2025

1,524

At 31 March 2024

2,033

5.	Investment property

Total

£

Fair value

At 1 April 2024

and 31 March 2025

265,050

Net book value

At 31 March 2025

265,050

At 31 March 2024

265,050

6.

Debtors: amounts falling due within one year

31.3.25

31.3.24

£

£

Other debtors

35,290

35,290

7.

Creditors: amounts falling due within one year

31.3.25

31.3.24

£

£

Trade creditors

19,325

17,228

Corporation tax

6,522

10,406

Social security and other taxes

1,520

925

Proposed dividends

30,000

29,953

Accrued expenses

5,854

3,155

63,221

61,667

8.

Creditors: amounts falling due after more than one year

31.3.25

31.3.24

£

£

Bank loans (see note 9)

28,704

32,900

9.

Loans

An analysis of the maturity of loans is given below:

31.3.25

31.3.24

£

£

Amounts falling due between one and two years:

Bank loans > 1 year

28,704

32,900